- Home
- GENI vs PRCT Comparison
GENI vs PRCT Comparison
Compare GENI & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GENI | PRCT |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United Kingdom | United States |
| Employees | N/A | 756 |
| Industry | Services-Misc. Amusement & Recreation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | GENI | PRCT |
|---|---|---|
| Price | $10.87 | $36.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | $14.47 | ★ $56.57 |
| AVG Volume (30 Days) | ★ 7.0M | 1.6M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $604,524,000.00 | $299,907,000.00 |
| Revenue This Year | $30.73 | $48.34 |
| Revenue Next Year | $16.92 | $29.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 30.70 | ★ 50.07 |
| 52 Week Low | $8.15 | $27.80 |
| 52 Week High | $13.73 | $98.38 |
Technical Indicators
Market Signals| Indicator | GENI | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 63.94 |
| Support Level | $9.82 | $29.04 |
| Resistance Level | $11.58 | $32.93 |
| Average True Range (ATR) | 0.54 | 1.76 |
| MACD | 0.27 | 0.84 |
| Stochastic Oscillator | 75.38 | 81.52 |
Price Performance
Historical ComparisonAbout GENI Genius Sports Limited
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas including Sports Technology and Services; Betting Technology, Content and Services; and Media Technology, Content and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content and Services division. Geographically, the company derives a majority of its revenue from Europe.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.